Immunization News and Research

RSS

Study captures the immune effect of COVID-19 vaccine in patients with multiple myeloma

Most immunocompromised people with a blood cancer called multiple myeloma benefited from a third dose of COVID-19 vaccines, a promising sign after it was shown that two doses tended to not be sufficient for them.

6 Apr 2022

Investigating high rate of Omicron sublineage breakthrough infections in triple vaccinated healthcare workers

Researchers identified breakthrough infections by Omicron sublineages BA.1, BA.1.1, and BA.2 in triple-vaccinated healthcare workers of Sweden.

6 Apr 2022

Self-assembling SARS-CoV-2 spike protein-directed nanoparticle vaccines

A new preprint study depicted the generation of self-assembling coronavirus disease 2019 (COVID-19) nanoparticle vaccines.

6 Apr 2022

Study shows circular RNA vaccine provides robust protection against SARS-CoV-2 in mice and rhesus macaques

Researchers investigated the effectiveness of a circRNA vaccine against SARS-CoV-2 and its Delta and Omicron variants, which elicited significant antibody and T-cell responses in mice and rhesus macaques.

6 Apr 2022

Why Black and Hispanic seniors are left with a less powerful flu vaccine

At Whitman-Walker Health, Dr. David Fessler and his staff administer high-dose influenza vaccine to all HIV-positive and senior patients.

6 Apr 2022

Developing and manufacturing custom recombinant antibodies for R&D

In this interview, Dr. Linlin Zhang, technical specialist for Sino Biological Europe, discusses how Sino is expanding its product offerings into the European market and outlines its process for developing and manufacturing custom recombinant antibodies for their clients.

From Sino Biological Inc. 6 Apr 2022

Swedish HCW study shows COVID booster shots have limited effect on Omicron

Researchers examine emerging infections in healthcare workers who received the booster vaccination either with or without prior SARS-CoV-2 infection.

5 Apr 2022

Does COVID-19 vaccination benefit those with prior SARS-CoV-2 infection?

Researchers evaluate the effectiveness of four COVID-19 vaccines against symptomatic infection, hospitalization, and death in convalescent individuals.

5 Apr 2022

Study on the efficacy of a BNT162b2 booster dose in the elderly

In a recent study posted to the medRxiv* preprint server, researchers characterized the immune responses against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Omicron variant after receiving a booster dose of BNT162b2 vaccine in older people.

5 Apr 2022

SARS-CoV-2 prevalence during the initial period of SARS-CoV-2 Omicron variant emergence in Finland

A recent study presented the rapid spike in COVID-19 seroprevalence during the emergence of the Omicron variant in Finland.

4 Apr 2022

How well does the BNT162b2 vaccine protect children and teens against Omicron?

A study published in the New England Journal of Medicine investigated the vaccine efficiency of the Pfizer BioNTech (BNT162b2) vaccine against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant in children and adolescents.

4 Apr 2022

COVID-19 vaccine can cause temporary delay in menstruation

Both the first and second doses of COVID-19 vaccines were related to a modest delay in menstruation.

3 Apr 2022

Study investigates messenger ribonucleic acid-based SARS-CoV-2 vaccine efficacy against SARS-CoV-2 Omicron in Denmark

A new study assessed the efficacy of two SARS-CoV-2 vaccines against Omicron infections and disease-related hospitalization in the Denmark population.

1 Apr 2022

Scientists explore impact of SARS-CoV-2 natural immunity on vaccine-induced immunity

A new study investigated the impact of pre-existing SARS-CoV-2 infection-induced immunity on vaccine-induced immunity.

31 Mar 2022

Mosaic-8 RBD-nanoparticles show promise as a vaccine candidate for SARS-CoV-2 and potential sarbecoviruses spillovers

Researchers designed nanoparticles representing RBDs of the S protein of animal sarbecoviruses and SARS-CoV-2 to evaluate their potential as a pan-sarbecovirus vaccine candidate.

31 Mar 2022

‘The danger is still there’ ― As omicron lurks, Native Americans are wary of boosters

When covid-19 vaccines first became available, Native Americans acted swiftly and with determination to get their shots — as though they had everything to lose.

31 Mar 2022

Preclinical investigation of intranasal adjuvanted COVID-19 vaccine

A new study reported systemic and mucosal immunity against SARS-CoV-2 via intranasal delivery of a vaccine containing recombinant SARS-CoV-2 antigens, nucleocapsid, and spike subunit.

30 Mar 2022

The potential efficacy of nasal nanoparticle COVID-19 vaccines

The current paper reviews progress in this field regarding nasal nanoparticle vaccines for COVID-19.

30 Mar 2022

A ferritin nanoparticle candidate vaccine for COVID

In a recent study published on the bioRxiv* preprint server, the immunogenicity, and effectiveness of SARS-CoV-2 spike ferritin nanoparticle (SpFN) adjuvanted with aluminum hydroxide (AlOH3) or Army Liposomal Formulation QS-21 (ALFQ) in a cynomolgus macaque (CM) COVID-19 model was evaluated.

30 Mar 2022

Study provides further assurances about the safety of COVID-19 vaccination during pregnancy

Researchers have found that receiving a COVID-19 vaccine during pregnancy does not lead to increases in the frequency of complications around the time of childbirth.

29 Mar 2022

Immunization News and Research

Study captures the immune effect of COVID-19 vaccine in patients with multiple myeloma

Investigating high rate of Omicron sublineage breakthrough infections in triple vaccinated healthcare workers

Self-assembling SARS-CoV-2 spike protein-directed nanoparticle vaccines

Study shows circular RNA vaccine provides robust protection against SARS-CoV-2 in mice and rhesus macaques

Why Black and Hispanic seniors are left with a less powerful flu vaccine

Developing and manufacturing custom recombinant antibodies for R&D

Swedish HCW study shows COVID booster shots have limited effect on Omicron

Does COVID-19 vaccination benefit those with prior SARS-CoV-2 infection?

Study on the efficacy of a BNT162b2 booster dose in the elderly

SARS-CoV-2 prevalence during the initial period of SARS-CoV-2 Omicron variant emergence in Finland

How well does the BNT162b2 vaccine protect children and teens against Omicron?

COVID-19 vaccine can cause temporary delay in menstruation

Study investigates messenger ribonucleic acid-based SARS-CoV-2 vaccine efficacy against SARS-CoV-2 Omicron in Denmark

Scientists explore impact of SARS-CoV-2 natural immunity on vaccine-induced immunity

Mosaic-8 RBD-nanoparticles show promise as a vaccine candidate for SARS-CoV-2 and potential sarbecoviruses spillovers

‘The danger is still there’ ― As omicron lurks, Native Americans are wary of boosters

Preclinical investigation of intranasal adjuvanted COVID-19 vaccine

The potential efficacy of nasal nanoparticle COVID-19 vaccines

A ferritin nanoparticle candidate vaccine for COVID

Study provides further assurances about the safety of COVID-19 vaccination during pregnancy

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News